Results 41 to 50 of about 268 (127)

Antioxidant supplementation and serum lipids in patients with Graves'disease : effect on LDL-cholesterol

Acta pharmaceutica, 2012
The effect of supplementation with a fixed combination of antioxidants on serum lipids was monitores in patients with newly detected Graves' disease.
Rahelić, Dario, Mayer, Ljiljana, Bačić Vrca, Vesna, Marušić, Srećko   +3 more
openaire  

Serologic Testing for Celiac Disease in Graves' Hyperthyroidism: Should We Act Early?

, 2021
Background: The general practice is to screen patients with autoimmune thyroid disease for celiac disease (CD); however, optimal timing for CD screening for patients with Graves'Disease (GD) has not been identified yet.
Demirpence, Hande, Caklili, Ozge Telci, Yarman, Sema   +2 more
core   +1 more source

Diagnostic imaging in thyrotoxicosis

, 1999
In thyrotoxicosis, imaging mainly scintigraphy, color Doppler sonography and radioiodine uptake test are used in the differential diagnosis as well as in the morphofunctional evaluation of the thyroid before and after therapy (mainly pharmacological or ...
Summaria, Vincenzo, Rufini, Vittoria, Mirk, Paoletta, Salvatori, Massimo, Romani, Maurizio   +4 more
core  

Mouse Models of Graves' Disease

, 2005
Graves' disease is characterized by overstimulation of the thyroid gland with agonistic autoantibodies against the thyrotropin (TSH) receptor, leading to hyperthyroidism and diffuse hyperplasia of the thyroid gland.
Nagayama, Yuji
core  

Increase of interferon-γ inducible α chemokine (C-X-C motif) ligand (CXCL)9 and CXCL11 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. [PDF]

, 2013
Background: Chemokine (C-X-C motif) ligand (CXCL)9 and CXCL11 play an important role in the initial phases of autoimmune thyroiditis (AT); however their serum levels in patients with Graves'disease (GD) have never been evaluated in relation to thyroid ...
Corrado A, Fallahi P., ANTONELLI, ALESSANDRO, FERRANNINI, ELEUTERIO, Ferrari SM   +4 more
core   +1 more source

Effective Inhibition of Thyroid Antigen Presentation Using Retro-Inverso Peptides in Experimental Autoimmune Thyroiditis: A Pathway Toward Immune Therapies of Thyroid Autoimmunity. [PDF]

Thyroid, 2023
Li CW, Osman R, Menconi F, Hou H, Schechter C, Kozhakhmetova A, Tomer Y.   +6 more
europepmc   +1 more source

Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease. [PDF]

Thyroid, 2021
Kim J, Choi MS, Park J, Park H, Jang HW, Jang HW, Choe JH, Kim JH, Kim JS, Cho YS, Choi JY, Kim TH, Chung JH, Kim SW.   +13 more
europepmc   +1 more source

Choice of treatment for Graves' disease

, 2015
Graves'disease is the second common endocrine disease found in the clinic, characterized by hyperthyroidism, ophthalmopathy, diffuse struma with/without dermopathy.CoMmon treatments for hyperthyroidism of Graves' disease are anti thyroid drugs, subtotal ...
Siti Nurdjanah, Siti Nurdjanah
core  

Reactivity of the T-Cells in Graves'disease to human thyroglobulin and synthetic peptides [PDF]

, 1997
Graves' disease is a common organ specific disorder characterized by immune response toward a number of thyroid proteins including thyroglobulin (Tg) , thyroid peroxidase (TPO) , and TSH receptor.
降旗, 謙一, 春日, 好雄, 奥山, 英理子, 吉沢, 要, 加藤, 亮二, 亀子, 文子   +5 more
core   +1 more source

Antithyroid drugs in the treatment of hyperthyroidism of Graves'disease: Long-term follow-up of 434 patients

, 1989
A study of antithyroid (ATD) therapy with a mean follow-up period of 10 years (range 2-25) in 434 patients with Graves'diseases has been made by linking hospital records with those of a central follow-up register.
Hedley, AJ, Young, RE, Alexander, WD, Jones, SJ, Bewsher, PD   +4 more
core   +1 more source